Accumulation of lopinavir resistance-associated mutations over 3 years follow-up of patients on highly active antiretroviral therapy: implication in salvage therapy.
Tsuchiya
K
K
AIDS Clinical Center, International Medical Center of Japan, Tokyo.
Matsuoka
S
S
Hachiya
A
A
Yasuoka
A
A
Tachikawa
N
N
Kikuchi
Y
Y
Genka
I
I
Teruya
K
K
Kimura
S
S
Oka
S
S
D023241:Antiretroviral Therapy, Highly Active; D004352:Drug Resistance, Microbial; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D061466:Lopinavir; D016296:Mutagenesis; D011744:Pyrimidinones / Q000494:pharmacology / Q000627:therapeutic use*; D012189:Retrospective Studies; D016879:Salvage Therapy; D013997:Time Factors
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir